February 20, 2024 · Form 4 insider transaction
Tatsis Ourania sold 480 shares of Vertex Pharmaceuticals Incorporated at $420.79 per share, a transaction worth $202.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 05/09/2023.